520 related articles for article (PubMed ID: 28712700)
61. Bilateral asymmetry of quantitative parenchymal kinetics at ultrafast DCE-MRI predict response to neoadjuvant chemotherapy in patients with HER2+ breast cancer.
Ren Z; Pineda FD; Howard FM; Fan X; Nanda R; Abe H; Kulkarni K; Karczmar GS
Magn Reson Imaging; 2023 Dec; 104():9-15. PubMed ID: 37611646
[TBL] [Abstract][Full Text] [Related]
62. Quantitative analysis of lesion morphology and texture features for diagnostic prediction in breast MRI.
Nie K; Chen JH; Yu HJ; Chu Y; Nalcioglu O; Su MY
Acad Radiol; 2008 Dec; 15(12):1513-25. PubMed ID: 19000868
[TBL] [Abstract][Full Text] [Related]
63. Role of sureness in evaluating AI/CADx: Lesion-based repeatability of machine learning classification performance on breast MRI.
Whitney HM; Drukker K; Vieceli M; Van Dusen A; de Oliveira M; Abe H; Giger ML
Med Phys; 2024 Mar; 51(3):1812-1821. PubMed ID: 37602841
[TBL] [Abstract][Full Text] [Related]
64. Characterization of spatiotemporal changes for the classification of dynamic contrast-enhanced magnetic-resonance breast lesions.
Milenković J; Hertl K; Košir A; Zibert J; Tasič JF
Artif Intell Med; 2013 Jun; 58(2):101-14. PubMed ID: 23548472
[TBL] [Abstract][Full Text] [Related]
65. Radiomics-Based Pretherapeutic Prediction of Non-response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer.
Zhou X; Yi Y; Liu Z; Cao W; Lai B; Sun K; Li L; Zhou Z; Feng Y; Tian J
Ann Surg Oncol; 2019 Jun; 26(6):1676-1684. PubMed ID: 30887373
[TBL] [Abstract][Full Text] [Related]
66. Early prediction of pathologic complete response of breast cancer after neoadjuvant chemotherapy using longitudinal ultrafast dynamic contrast-enhanced MRI.
Cao Y; Wang X; Li L; Shi J; Zeng X; Huang Y; Chen H; Jiang F; Yin T; Nickel D; Zhang J
Diagn Interv Imaging; 2023 Dec; 104(12):605-614. PubMed ID: 37543490
[TBL] [Abstract][Full Text] [Related]
67. Improving the Accuracy of Computer-aided Diagnosis for Breast MR Imaging by Differentiating between Mass and Nonmass Lesions.
Gallego-Ortiz C; Martel AL
Radiology; 2016 Mar; 278(3):679-88. PubMed ID: 26383229
[TBL] [Abstract][Full Text] [Related]
68. Intratumoral and peritumoral radiomics based on dynamic contrast-enhanced MRI for preoperative prediction of intraductal component in invasive breast cancer.
Xu H; Liu J; Chen Z; Wang C; Liu Y; Wang M; Zhou P; Luo H; Ren J
Eur Radiol; 2022 Jul; 32(7):4845-4856. PubMed ID: 35079887
[TBL] [Abstract][Full Text] [Related]
69. Texture analysis on MR images helps predicting non-response to NAC in breast cancer.
Michoux N; Van den Broeck S; Lacoste L; Fellah L; Galant C; Berlière M; Leconte I
BMC Cancer; 2015 Aug; 15():574. PubMed ID: 26243303
[TBL] [Abstract][Full Text] [Related]
70. Radiomic analysis on magnetic resonance diffusion weighted image in distinguishing triple-negative breast cancer from other subtypes: a feasibility study.
Wang Q; Mao N; Liu M; Shi Y; Ma H; Dong J; Zhang X; Duan S; Wang B; Xie H
Clin Imaging; 2021 Apr; 72():136-141. PubMed ID: 33242692
[TBL] [Abstract][Full Text] [Related]
71. Predictive value of DCE-MRI for early evaluation of pathological complete response to neoadjuvant chemotherapy in resectable primary breast cancer: A single-center prospective study.
Sun YS; He YJ; Li J; Li YL; Li XT; Lu AP; Fan ZQ; Cao K; Ouyang T
Breast; 2016 Dec; 30():80-86. PubMed ID: 27652977
[TBL] [Abstract][Full Text] [Related]
72. DCE-MRI analysis methods for predicting the response of breast cancer to neoadjuvant chemotherapy: pilot study findings.
Li X; Arlinghaus LR; Ayers GD; Chakravarthy AB; Abramson RG; Abramson VG; Atuegwu N; Farley J; Mayer IA; Kelley MC; Meszoely IM; Means-Powell J; Grau AM; Sanders M; Bhave SR; Yankeelov TE
Magn Reson Med; 2014 Apr; 71(4):1592-602. PubMed ID: 23661583
[TBL] [Abstract][Full Text] [Related]
73. Machine learning classification of texture features of MRI breast tumor and peri-tumor of combined pre- and early treatment predicts pathologic complete response.
Hussain L; Huang P; Nguyen T; Lone KJ; Ali A; Khan MS; Li H; Suh DY; Duong TQ
Biomed Eng Online; 2021 Jun; 20(1):63. PubMed ID: 34183038
[TBL] [Abstract][Full Text] [Related]
74. Textural analysis of early-phase spatiotemporal changes in contrast enhancement of breast lesions imaged with an ultrafast DCE-MRI protocol.
Milenković J; Dalmış MU; Žgajnar J; Platel B
Med Phys; 2017 Sep; 44(9):4652-4664. PubMed ID: 28622412
[TBL] [Abstract][Full Text] [Related]
75. Radiomic features of Pk-DCE MRI parameters based on the extensive Tofts model in application of breast cancer.
Zhou X; Gao F; Duan S; Zhang L; Liu Y; Zhou J; Bai G; Tao W
Phys Eng Sci Med; 2020 Jun; 43(2):517-524. PubMed ID: 32524436
[TBL] [Abstract][Full Text] [Related]
76. Breast DCE-MRI radiomics: a robust computer-aided system based on reproducible BI-RADS features across the influence of datasets bias and segmentation methods.
Qiao M; Li C; Suo S; Cheng F; Hua J; Xue D; Guo Y; Xu J; Wang Y
Int J Comput Assist Radiol Surg; 2020 Jun; 15(6):921-930. PubMed ID: 32388693
[TBL] [Abstract][Full Text] [Related]
77. Potential of computer-aided diagnosis of high spectral and spatial resolution (HiSS) MRI in the classification of breast lesions.
Bhooshan N; Giger M; Medved M; Li H; Wood A; Yuan Y; Lan L; Marquez A; Karczmar G; Newstead G
J Magn Reson Imaging; 2014 Jan; 39(1):59-67. PubMed ID: 24023011
[TBL] [Abstract][Full Text] [Related]
78. Monitoring neoadjuvant chemotherapy in breast cancer patients: improved MR assessment at 3 T?
Heldahl MG; Lundgren S; Jensen LR; Gribbestad IS; Bathen TF
J Magn Reson Imaging; 2011 Sep; 34(3):547-56. PubMed ID: 21761463
[TBL] [Abstract][Full Text] [Related]
79. Radiomic signatures derived from multiparametric MRI for the pretreatment prediction of response to neoadjuvant chemotherapy in breast cancer.
Bian T; Wu Z; Lin Q; Wang H; Ge Y; Duan S; Fu G; Cui C; Su X
Br J Radiol; 2020 Nov; 93(1115):20200287. PubMed ID: 32822542
[TBL] [Abstract][Full Text] [Related]
80. Development of MRI-Based Deep Learning Signature for Prediction of Axillary Response After NAC in Breast Cancer.
Zhang B; Yu Y; Mao Y; Wang H; Lv M; Su X; Wang Y; Li Z; Zhang Z; Bian T; Wang Q
Acad Radiol; 2024 Mar; 31(3):800-811. PubMed ID: 37914627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
